Table 2.
Percent (%) susceptibility of reported isolates of A succinoproducens to different antibioticsa
| Antibiotic | No. isolates | Percent of susceptibility, n (%) | Methods used (no. isolates) | References |
|---|---|---|---|---|
| Penicillin | 12 | 41.7 (5/12) | Disk diffusion (7), dilution method (4), E-test (1) | 3, 4, 10, 12, 18, 20, 21, 23, 24 |
| Amoxicillin | 6 | 83.3 (5/6) | Disk diffusion (5), E-test (1) | 10, 12, 13, 23, 24 |
| Amoxicillin-clavulanate | 7 | 100 (7/7) | Disk diffusion (5), dilution methods (1), E-test (1) | 3, 4, 10, 12, 13 |
| Ticarcillin-clavulanate | 4 | 100 (4/4) | Disk diffusion (3), E-test (1) | 3, 12 |
| Cephalothin | 7 | 71.4 (5/7) | Disk diffusion (4), dilution methods (3) | 18, 20, 21, 23, 24 |
| Cefamandole | 1 | 100 (1/1) | Disk diffusion (1) | 18 |
| Cefuroxime | 1 | 100 (1/1) | E-test (1) | 12 |
| Cefoxitin | 5 | 100 (5/5) | Dilution methods (5) | 4, 20, 21 |
| Cefotaxime | 5 | 100 (5/5) | Disk diffusion (1), dilution methods (3), E-test (1) | 12, 13, 20, 21 |
| Imipenem | 4 | 100 (4/4) | Disk diffusion (3), dilution methods (1) | 3, 4 |
| Chloramphenicol | 13 | 100 (13/13) | Disk diffusion (9), dilution methods (4) | 3, 10, 13, 18, 20, 21, 23, 24 |
| Metronidazole | 12 | 25 (3/12) | Disk diffusion (6), dilution methods (5), E-test (1) | 3, 4, 10, 12, 13, 18, 21 |
| Clindamycin | 10 | 10 (1/10) | Disk diffusion (5), dilution methods (5) | 3, 4, 10, 20, 21, 24 |
| Erythromycin | 11 | 27.3 (3/11) | Disk diffusion (6), dilution methods (4), E-test (1) | 3, 4, 10, 12, 13, 20, 21, 23, 24 |
| Tetracycline | 7 | 71.4 (5/7) | Disk diffusion (3), dilution methods (4) | 20, 21, 23, 24 |
| Gentamicin | 1 | 100 (1/1) | Disk diffusion (1) | 18 |
| TMP-SMZ | 1 | 100 (1/1) | Disk diffusion (1) | 18 |
| Ciprofloxacin | 4 | 100 (4/4) | Disk diffusion (4) | 3, 13 |
| Nalidixic acid | 1 | 0 (0/1) | Disk diffusion (1) | 18 |
| Vancomycin | 3 | 0 (3/3) | Disk diffusion (3) | 18, 23 |
a
TMP-SMZ, trimethoprim-sulfamethoxazole.